DAIICHI SANKYO COMPANY LIMITED / Immediate Release Company / Tokyo Stock Exchange / /
Continent
Europe / /
Country
Japan / /
Event
FDA Phase / M&A / /
Facility
Pharmaceutical Development Support Center / /
MedicalCondition
methemoglobinemia treatment / loss of consciousness / toxic disorder / toxic methemoglobinemia / headache / shortness of breath / dizziness / /
Organization
Review Committee on Unapproved Drugs and Indications / Pharmaceutical Development Support Center / Ministry of Health / /
Person
Joji Nakayama / Noriaki Ishida / / /
Position
Director / President and CEO / Representative / Corporate Officer / Vice President / Corporate Communications Department Telephone / /
Product
Methemoglobinemia Treatment Methylene Blue Injection / Methylene Blue Injection / U.S. Product Overview Product name Methylene Blue Injection / Japan / /
Microsoft Word - 20150105_Daiichi Sankyo - Approval Press release_Final.docx